Low dose tadalafil vs solifenacin for overactive bladder in women
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had overactive bladder symptoms for at least 3 months.
- Your symptoms are moderate to severe (based on a standardized score).
- You do not have a current urinary tract infection.
- You do not have stress incontinence (leakage with cough/sneeze) as your main problem.
- You are not pregnant or breastfeeding.
- You do not have uncontrolled diabetes (HbA1c over 7).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
This study compares two pills (solifenacin and mirabegron) for treating overactive bladder. It aims to see which works better and has fewer side effects. You may qualify if you're newly diagnosed and haven't tried these medicines before.
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
This study compares vaginal estradiol (a hormone placed in the vagina) versus an oral beta-3 medicine called mirabegron for overactive bladder symptoms. It looks to see which treatment works better and is safer for postmenopausal women.
This study compares two ways to help women with overactive bladder get treatment and stick with it. You might be able to join if you are a woman with ongoing OAB symptoms and haven't had certain treatments recently.
This study tests a new bladder treatment called NT 201 combined with a device called the Vibe System for women with overactive bladder (frequent, urgent need to urinate). The treatment is injected directly into the bladder and may help reduce urgency and leaking.
Hear when a new Overactive Bladder (OAB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.